4.4 Editorial Material

The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates

Related references

Note: Only part of the references are listed.
Article Oncology

Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis

Gregg S. Wilkinson et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

Article Endocrinology & Metabolism

Jaw osteonecrosis related to bisphosphonate therapy:: A severe secondary disorder

C. Dannemann et al.

Article Dentistry, Oral Surgery & Medicine

Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma

Rossi Diego et al.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2007)

Article Dentistry, Oral Surgery & Medicine

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management

Salvatore L. Ruggiero et al.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2006)

Article Dentistry, Oral Surgery & Medicine

Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century?

JW Hellstein et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2005)

Article Clinical Neurology

Periodontal disease as a risk factor for ischemic stroke

AJ Grau et al.

STROKE (2004)

Article Dentistry, Oral Surgery & Medicine

Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases

SL Ruggiero et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)

Article Oncology

Bisphosphonates: Preclinical review

JR Green

ONCOLOGIST (2004)

Letter Oncology

Bisphosphanates and oral cavity avascular bone necrosis

CA Migliorati

JOURNAL OF CLINICAL ONCOLOGY (2003)

Letter Dentistry, Oral Surgery & Medicine

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic

RE Marx

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)

Article Pharmacology & Pharmacy

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

J Wood et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)